Burong Hu

Burong Hu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cancer Letters
Verified
Journal Article
Closed access
GXGang Xue
Gang Xue
ZRZhenxin Ren
Zhenxin Ren
YCYaxiong Chen
Yaxiong Chen
JZJiayun Zhu
Jiayun Zhu
YDYarong Du
Yarong Du
BHBurong Hu
Burong Hu

22 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
MSMeng Sun
Meng Sun
DPDong Pan
Dong Pan
YCYaxiong Chen
Yaxiong Chen
YLYa Li
Ya Li
KGKun Gao
Kun Gao
BHBurong Hu
Burong Hu
Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway

17 June 2015 in Cell Cycle
Verified
Journal Article
Open access
JZJiayun Zhu
Jiayun Zhu
FSFengtao Su
Fengtao Su
SMShibani Mukherjee
Shibani Mukherjee
EMEiichiro Mori
Eiichiro Mori
BHBurong Hu
Burong Hu
AAAsaithamby Aroumougame
Asaithamby Aroumougame
Fanconi Anemia (FA) is a cancer predisposition syndrome and the factors defective in FA are involved in DNA replication, DNA damage repair and tumor suppression. Here, we show that FANCD2 is critical for genome stability maintenance in response to high-linear energy transfer (LET) radiation. We found that FANCD2 is monoubiquitinated and recruited to the sites of clustered DNA double-stranded breaks (DSBs) specifically in S/G2 cells after high-LET radiation. Further, FANCD2 facilitated the repair of clustered DSBs in S/G2 cells and proper progression of S-phase. Furthermore, lack of FANCD2 led to a reduced rate of replication fork progression and elevated levels of both replication fork stalling and new origin firing in response to high-LET radiation. Mechanistically, FANCD2 is required for correct recruitment of RPA2 and Rad51 to the sites of clustered DSBs and that is critical for proper processing of clustered DSBs. Significantly, FANCD2-decifient cells exhibited defective chromosome segregation, elevated levels of chromosomal aberrations, and anchorage-independent growth in response to high-LET radiation. These findings establish FANCD2 as a key factor in genome stability maintenance in response to high-LET radiation and as a promising target to improve cancer therapy.

16 April 2015 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
GXGang Xue
Gang Xue
ZRZhenxin Ren
Zhenxin Ren
PGPeter W. Grabham
Peter W. Grabham
YCYaxiong Chen
Yaxiong Chen
JZJiayun Zhu
Jiayun Zhu
BHBurong Hu
Burong Hu
In vitro 3D growth of tumors is a new cell culture model that more closely mimics the features of the in vivo environment and is being used increasingly in the field of biological and medical research. It has been demonstrated that cancer cells cultured in 3D matrices are more radio-resistant compared with cells in monolayers. However, the mechanisms causing this difference remain unclear. Here we show that cancer cells cultured in a 3D microenvironment demonstrated an increase in cells with stem cell properties. This was confirmed by the finding that cells in 3D cultures upregulated the gene and protein expression of the stem cell reprogramming factors such as OCT4, SOX2, NANOG, LIN28 and miR-302a, compared with cells in monolayers. Moreover, the expression of β-catenin, a regulating molecule of reprogramming factors, also increased in 3D-grown cancer cells. These findings suggest that cancer cells were reprogrammed to become stem cell–like cancer cells in a 3D growth culture microenvironment. Since cancer stem cell–like cells demonstrate an increased radio-resistance and chemo-resistance, our results offer a new perspective as to why. Our findings shed new light on understanding the features of the 3D growth cell model and its application in basic research into clinical radiotherapy and medicine.

12 February 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DZDeng-Gao Zhao
Deng-Gao Zhao
JCJianJun Chen
JianJun Chen
YDYa-Rong Du
Ya-Rong Du
YMYan-Yan Ma
Yan-Yan Ma
YCYa-Xiong Chen
Ya-Xiong Chen
BHBurong Hu
Burong Hu

15 July 2022 in Respiratory Research
Verified
Journal Article
Open access
PDF file
QLQuan Li
Quan Li
PZPan Zhang
Pan Zhang
HHHuixiao Hu
Huixiao Hu
HHHang Huang
Hang Huang
DPDong Pan
Dong Pan
BHBurong Hu
Burong Hu
Background: As a DNA surveillance mechanism, cell cycle checkpoint has recently been discovered to be closely associated with lung adenocarcinoma (LUAD) prognosis. It is also an essential link in the process of DNA damage repair (DDR) that confers resistance to radiotherapy. Whether genes that have both functions play a more crucial role in LUAD prognosis remains unclear. Methods: In this study, DDR-related genes with cell cycle checkpoint function (DCGs) were selected to investigate their effects on the prognosis of LUAD. The TCGA-LUAD cohort and two GEO external validation cohorts (GSE31210 and GSE42171) were performed to construct a prognosis model based on the least absolute shrinkage and selection operator (LASSO) regression. Patients were divided into high-risk and low-risk groups based on the model. Subsequently, the multivariate COX regression was used to construct a prognostic nomogram. The ssGSEA, CIBERSORT algorithm, TIMER tool, CMap database, and IC50 of chemotherapeutic agents were used to analyze immune activity and responsiveness to chemoradiotherapy. Results: 4 DCGs were selected as prognostic signatures, and patients in the high-risk group had a lower overall survival (OS). The lower infiltration levels of immune cells and the higher expression levels of immune checkpoints appeared in the high-risk group. The damage repair pathways were upregulated, and chemotherapeutic agent sensitivity was poor in the high-risk group. Conclusions: The 4-DCGs signature prognosis model we constructed could predict the survival rate, immune activity, and chemoradiotherapy responsiveness of LUAD patients.